COVID-19 Research
The Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the COVID-19 respiratory disease. SARS-CoV-2 is highly contagious and transmits predominantly via the respiratory route. It is an enveloped virus with a single-stranded RNA genome. Small molecules can be used to investigate the virus and the corresponding immune response. Researchers can save up to 50% on high purity Covid-19 research products - they are up to half the price of other suppliers.
View products: Compound repurposing | Virus attachment / entry | Viral replication | Cytokine storm | Organoids | Cell culture reagents | Cell stains, viability & proliferation | CRISPR / gene editing
GYKI 52466 hydrochloride (HB0311)
Description:Selective, non-competitive AMPA receptor antagonist
Purity:>98%
-
GYKI 53655 hydrochloride (HB0312)
Description:Non-competitive AMPA receptor antagonist. Also blocks kainate GluK3 homomeric receptors.
Purity:>98%
-
Ifenprodil (HB0339)
Description:Non-competitive GluN2B subunit selective NMDAR allosteric inhibitor
Purity:>99%
-
-
Kynurenic acid (HB0362)
Description:Endogenous ionotropic glutamate / nicotinic antagonist.
Purity:>98%
-
Kynurenic acid sodium salt (HB0363)
Description:Endogenous ionotropic glutamate / nicotinic antagonist. Sodium salt.
Purity:>98%
-
-
Methyllycaconitine citrate (MLA) (HB2026)
Description:Potent, selective α7 nicotinic receptor antagonist
Purity:>95%
-
(+)-MK 801 maleate (HB0004)
Description:Potent, selective, non-competitive NMDA receptor antagonist
Purity:>98%
- Description:
Less active enantiomer of (+)-MK 801. NMDA receptor antagonist.
Purity:>99%
